JP2004502684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502684A5 JP2004502684A5 JP2002507800A JP2002507800A JP2004502684A5 JP 2004502684 A5 JP2004502684 A5 JP 2004502684A5 JP 2002507800 A JP2002507800 A JP 2002507800A JP 2002507800 A JP2002507800 A JP 2002507800A JP 2004502684 A5 JP2004502684 A5 JP 2004502684A5
- Authority
- JP
- Japan
- Prior art keywords
- ortho
- mammal
- substituents
- administering
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020002739 Catechol O-methyltransferase Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20001593A FI20001593A7 (fi) | 2000-07-03 | 2000-07-03 | Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia |
| FI20001593 | 2000-07-03 | ||
| PCT/FI2001/000613 WO2002002548A1 (en) | 2000-07-03 | 2001-06-28 | Coumarin derivatives with comt inhibiting activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004502684A JP2004502684A (ja) | 2004-01-29 |
| JP2004502684A5 true JP2004502684A5 (enExample) | 2005-02-03 |
| JP4851051B2 JP4851051B2 (ja) | 2012-01-11 |
Family
ID=8558717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002507800A Expired - Fee Related JP4851051B2 (ja) | 2000-07-03 | 2001-06-28 | Ｃｏｍｔ阻害活性を有するクマリン誘導体 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6951870B2 (enExample) |
| EP (1) | EP1301503B1 (enExample) |
| JP (1) | JP4851051B2 (enExample) |
| KR (1) | KR20030040225A (enExample) |
| CN (1) | CN1199963C (enExample) |
| AT (1) | ATE260268T1 (enExample) |
| AU (2) | AU7259701A (enExample) |
| BG (1) | BG107513A (enExample) |
| BR (1) | BR0111969A (enExample) |
| CA (1) | CA2414787C (enExample) |
| DE (1) | DE60102161T2 (enExample) |
| DK (1) | DK1301503T3 (enExample) |
| EE (1) | EE200300008A (enExample) |
| ES (1) | ES2215919T3 (enExample) |
| FI (1) | FI20001593A7 (enExample) |
| HU (1) | HUP0301706A3 (enExample) |
| IL (2) | IL153352A0 (enExample) |
| MX (1) | MXPA02012657A (enExample) |
| NO (1) | NO328699B1 (enExample) |
| NZ (1) | NZ523121A (enExample) |
| PL (1) | PL359068A1 (enExample) |
| PT (1) | PT1301503E (enExample) |
| RU (1) | RU2282627C2 (enExample) |
| SK (1) | SK18452002A3 (enExample) |
| TR (1) | TR200400802T4 (enExample) |
| WO (1) | WO2002002548A1 (enExample) |
| ZA (1) | ZA200210161B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR846401A0 (en) * | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
| AU2003265737B2 (en) * | 2002-10-02 | 2008-10-16 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
| AU2002951833A0 (en) | 2002-10-02 | 2002-10-24 | Novogen Research Pty Ltd | Compositions and therapeutic methods invloving platinum complexes |
| CN1506359A (zh) | 2002-12-05 | 2004-06-23 | �й�ҽѧ��ѧԺҩ���о��� | 新的香豆素酰胺衍生物及其制法和其药物组合物与用途 |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| NZ553834A (en) | 2004-09-21 | 2010-03-26 | Novogen Res Pty Ltd | 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives |
| MY148644A (en) * | 2005-07-18 | 2013-05-15 | Orion Corp | New pharmaceutical compounds |
| EP1917245A1 (de) | 2005-08-21 | 2008-05-07 | Abbott GmbH & Co. KG | Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| WO2007124617A1 (fr) * | 2006-04-28 | 2007-11-08 | Institute Of Mataria Medica, Chinese Academy Of Medical Sciences | Dérivés de coumarine, leurs procédés de préparation, compositions pharmaceutiques et utilisations |
| RU2396244C1 (ru) * | 2008-12-23 | 2010-08-10 | Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) | Способ получения пурпурогаллина |
| ES2343347B2 (es) * | 2009-01-27 | 2011-12-07 | Universidade De Santiago De Compostela | Uso de derivados de 3-fenilcumarinas 6-sustituidas y preparacion de nuevos derivados. |
| ES2773732T3 (es) | 2010-11-01 | 2020-07-14 | Mei Pharma Inc | Composiciones de isoflavonoides y procedimientos para el tratamiento del cáncer |
| TWI638802B (zh) | 2012-05-24 | 2018-10-21 | 芬蘭商奧利安公司 | 兒茶酚ｏ－甲基轉移酶活性抑制化合物 |
| HUE054998T2 (hu) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Kombinációs terápiák emlõrák kezelésében való alkalmazásra |
| WO2017103278A1 (en) * | 2015-12-18 | 2017-06-22 | Caprotec Bioanalytics Gmbh | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease |
| CN107868069A (zh) * | 2017-10-31 | 2018-04-03 | 山东新华制药股份有限公司 | 7‑羟基‑8‑甲基‑6‑硝基‑2‑氧‑2h‑苯并吡喃‑3‑羧酸的制备工艺 |
| CN116064607B (zh) * | 2022-08-22 | 2025-04-18 | 西南大学 | 一种高活性o-甲基转移酶基因制备滨蒿内酯的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5035393A (enExample) * | 1973-08-01 | 1975-04-04 | ||
| US3973608A (en) | 1973-08-01 | 1976-08-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Microbial production of certain isoflavones |
| US5236952A (en) * | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
| US5283352A (en) * | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
| GB8816519D0 (en) | 1987-07-23 | 1988-08-17 | Ici Plc | Antibiotic compounds |
| HUT63843A (en) * | 1992-02-13 | 1993-10-28 | Biosignal Kutato Fejlesztoe Kf | Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| JP3166094B2 (ja) * | 1993-09-08 | 2001-05-14 | 森永乳業株式会社 | クマリン誘導体及びそれらの用途 |
| JPH0892157A (ja) | 1994-05-02 | 1996-04-09 | F Hoffmann La Roche Ag | プルプロガリン誘導体 |
| GB9626472D0 (en) * | 1996-12-20 | 1997-02-05 | Aperia Anita C | New use of comt inhibitors |
| HRP970529B1 (en) * | 1997-10-02 | 2003-06-30 | Pliva Pharm & Chem Works | Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof |
-
2000
- 2000-07-03 FI FI20001593A patent/FI20001593A7/fi unknown
-
2001
- 2001-06-28 ES ES01951741T patent/ES2215919T3/es not_active Expired - Lifetime
- 2001-06-28 HU HU0301706A patent/HUP0301706A3/hu unknown
- 2001-06-28 PL PL01359068A patent/PL359068A1/xx not_active Application Discontinuation
- 2001-06-28 MX MXPA02012657A patent/MXPA02012657A/es active IP Right Grant
- 2001-06-28 CA CA2414787A patent/CA2414787C/en not_active Expired - Fee Related
- 2001-06-28 DE DE60102161T patent/DE60102161T2/de not_active Expired - Lifetime
- 2001-06-28 PT PT01951741T patent/PT1301503E/pt unknown
- 2001-06-28 WO PCT/FI2001/000613 patent/WO2002002548A1/en not_active Ceased
- 2001-06-28 NZ NZ523121A patent/NZ523121A/en not_active IP Right Cessation
- 2001-06-28 SK SK1845-2002A patent/SK18452002A3/sk unknown
- 2001-06-28 US US10/312,817 patent/US6951870B2/en not_active Expired - Fee Related
- 2001-06-28 RU RU2003102894/04A patent/RU2282627C2/ru not_active IP Right Cessation
- 2001-06-28 JP JP2002507800A patent/JP4851051B2/ja not_active Expired - Fee Related
- 2001-06-28 IL IL15335201A patent/IL153352A0/xx unknown
- 2001-06-28 AU AU7259701A patent/AU7259701A/xx active Pending
- 2001-06-28 EP EP01951741A patent/EP1301503B1/en not_active Expired - Lifetime
- 2001-06-28 BR BR0111969-9A patent/BR0111969A/pt not_active IP Right Cessation
- 2001-06-28 AT AT01951741T patent/ATE260268T1/de active
- 2001-06-28 KR KR1020027017767A patent/KR20030040225A/ko not_active Ceased
- 2001-06-28 TR TR2004/00802T patent/TR200400802T4/xx unknown
- 2001-06-28 AU AU2001272597A patent/AU2001272597B9/en not_active Ceased
- 2001-06-28 CN CNB018121934A patent/CN1199963C/zh not_active Expired - Fee Related
- 2001-06-28 EE EEP200300008A patent/EE200300008A/xx unknown
- 2001-06-28 DK DK01951741T patent/DK1301503T3/da active
-
2002
- 2002-12-10 IL IL153352A patent/IL153352A/en not_active IP Right Cessation
- 2002-12-13 ZA ZA200210161A patent/ZA200210161B/en unknown
- 2002-12-18 NO NO20026095A patent/NO328699B1/no not_active IP Right Cessation
-
2003
- 2003-01-31 BG BG107513A patent/BG107513A/bg unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502684A5 (enExample) | ||
| CA2595544A1 (en) | Compounds having analgesic and/or immunostimulant activity | |
| JP2004533444A5 (enExample) | ||
| SE0301886D0 (sv) | New use V | |
| JP2005528325A5 (enExample) | ||
| SE0301882D0 (sv) | New use I | |
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| JP2007510667A5 (enExample) | ||
| JP2005522505A5 (enExample) | ||
| DE60319066D1 (de) | 1,4-disubstituierte benzokondensierte cycloalkyl-harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen | |
| SE0301888D0 (sv) | New use VII | |
| JP2013541514A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
| JP2009526751A5 (enExample) | ||
| IS8395A (is) | Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun | |
| JP2007519721A5 (enExample) | ||
| RU2008150250A (ru) | Способ лечения рака | |
| SE0203304D0 (sv) | Novel Coumpounds | |
| JP2007534743A5 (enExample) | ||
| JP2005502636A5 (enExample) | ||
| ATE516031T1 (de) | Verbindungen gegen krebs | |
| JP2011508779A5 (enExample) | ||
| JP2004538314A5 (enExample) | ||
| EP1627635A3 (en) | Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection |